VOYA Investment Management
ALXO icon

VOYA Investment Management’s ALX Oncology ALXO Stock Holding History

VOYA Investment Management’s Portfolio ALXO Stock Details ALXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,813
Closed -$23.3K – 2733
2024
Q3 		$23.3K Buy
12,813
+1,598
+14% +$5.94K ﹤0.01% 2804
2024
Q2 		$67.6K Buy
+11,215
New +$138K ﹤0.01% 2752
2024
Q1 		– Sell
-10,708
Closed -$159K – 2786
2023
Q4 		$159K Buy
+10,708
New +$102K ﹤0.01% 2642
2021
Q4 		– Sell
-6,946
Closed -$513K – 2776
2021
Q3 		$513K Sell
6,946
-200
-3% -$13.3K ﹤0.01% 2033
2021
Q2 		$391K Sell
7,146
-453
-6% -$27.1K ﹤0.01% 2235
2021
Q1 		$560K Buy
7,599
+3,427
+82% +$270K ﹤0.01% 1960
2020
Q4 		$360K Buy
+4,172
New +$251K ﹤0.01% 2104

Other funds holding ALXO

VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return

VOYA Investment Management's ALXO Position: Q4 2024 in Review

VOYA Investment Management sold out of ALX Oncology (ALXO) in Q4 2024, closing a stake of 12,813 shares — an estimated $23.3K sold.

VOYA Investment Management first reported a position in ALXO in Q4 2020 and held it in 7 quarters. The position peaked at $560K in Q1 2021. 87 funds tracked by Wall St. Rank hold ALXO as of Q4 2024.

  • VOYA Investment Management reported no remaining ALX Oncology position as of Q4 2024 after selling out during the quarter.
  • VOYA Investment Management sold 12,813 ALX Oncology shares in Q4 2024, an estimated $23.3K.
  • VOYA Investment Management first reported a position in ALX Oncology in Q4 2020 and held it in 7 quarters.
  • VOYA Investment Management's ALX Oncology position peaked at $560K in Q1 2021.
  • 87 funds tracked by Wall St. Rank held ALX Oncology as of Q4 2024.

Based on VOYA Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.